UroGen Pharma Employee Directory

UroGen Pharma corporate office is located in 400 Alexander Park Fl 4, Princeton, New Jersey, 08540, United States and has 201-500 employees.

Likely to Engage tag.Highly Engaged Employees

Employees by Department

Departments

Number of employees

Sales

67

Operations

56

Medical & Health

35

Engineering & Technical

16

Finance

14

Marketing

9

C-Suite

9

Key Employees of UroGen Pharma

  • MS
    United States flag for contact location.
    Mark Schoenber...

    Chief Medical Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

UroGen Pharma Global Presence

globalPresence illustration
North America51-200
Asia11-50
Europe1-10

Index of contact profiles from UroGen Pharma

Hundreds of professionals searching for UroGen Pharma have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12345

Former Employees at UroGen Pharma

Explore people who held key positions, contributed to UroGen Pharma's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in New Jersey, United States

Frequently Asked Questions Regarding UroGen Pharma Employees

How many employees does UroGen Pharma have?
UroGen Pharma has 201-500 employees
Who are UroGen Pharma key employees?
Some of UroGen Pharma key employees are Mark Schoenberg
Where is UroGen Pharma located?
UroGen Pharma’s headquarters are located at 400 Alexander Park Fl 4, Princeton, New Jersey, 08540, United States
How do I contact UroGen Pharma?
UroGen Pharma Contact Info: Phone number: (646) 768-9780 Website: www.urogen.com
What does UroGen Pharma do?

UroGen Pharma is a biopharmaceutical company focused on developing innovative therapeutic solutions for specialty cancers and urologic diseases. The company operates with a core mission to address unmet medical needs in areas where current treatment options remain limited, working to expand the arsenal of therapies available to patients facing comp... lex urologic conditions. The foundation of UroGen's approach rests on RTGel, a proprietary reverse-thermal hydrogel platform technology designed to fundamentally alter how medications interact with affected tissues. This sustained-release system enables prolonged drug exposure to the urinary tract, transforming localized therapy into a potentially more effective treatment modality compared to conventional administration methods. By engineering extended contact between therapeutic agents and target tissues, the platform addresses a critical gap in how specialty medications can be delivered and utilized. The company's clinical pipeline centers on mitomycin-based gel formulations engineered to treat non-muscle invasive urothelial cancers through non-surgical ablation. These investigational candidates target specific disease presentations, including low-grade upper tract urothelial cancer and low-muscle invasive bladder cancer, offering patients alternatives to traditional surgical interventions.Read More

Is UroGen Pharma a public company?
Yes, UroGen Pharma is a public company and is traded under the symbol URGN
See more information about UroGen Pharma Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.